Current Proteomics

Scope & Guideline

Connecting Researchers in the Dynamic World of Proteomics

Introduction

Welcome to your portal for understanding Current Proteomics, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1570-1646
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2005 to 2024
AbbreviationCURR PROTEOMICS / Curr. Proteomics
Frequency5 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

The journal 'Current Proteomics' focuses on advancing the field of proteomics through a variety of methodologies and applications. It serves as a platform for researchers to share novel findings, technological advancements, and insights into the molecular mechanisms underlying various biological processes and diseases.
  1. Proteomic Analysis and Characterization:
    The journal emphasizes studies that utilize proteomic techniques to analyze protein expression, modifications, and interactions. This includes quantitative proteomics, mass spectrometry, and protein profiling in various biological contexts.
  2. Computational Proteomics and Bioinformatics:
    A significant focus is placed on computational approaches to proteomics, including in silico studies, machine learning applications, and bioinformatics tools that assist in the interpretation of proteomic data and the prediction of protein functions.
  3. Drug Discovery and Therapeutic Applications:
    The journal features research that explores the role of proteomics in drug discovery, including the identification of potential biomarkers and therapeutic targets, as well as the evaluation of drug efficacy and mechanisms of action.
  4. Clinical Applications and Disease Mechanisms:
    Current Proteomics highlights studies that connect proteomic findings to clinical implications, disease mechanisms, and potential therapeutic strategies, thereby bridging the gap between basic research and clinical practice.
  5. Innovative Methodologies in Proteomics:
    The journal encourages submissions that report on novel proteomic techniques, including advancements in mass spectrometry, label-free quantification, and the integration of proteomics with other omics technologies.
Recent publications in 'Current Proteomics' indicate emerging themes that reflect current trends and interests in the field. These areas are gaining traction and are likely to shape future research directions.
  1. Integration of Omics Technologies:
    There is a growing trend towards integrating proteomics with genomics, metabolomics, and transcriptomics. This holistic approach allows for a more comprehensive understanding of biological systems and disease states.
  2. Proteomics in Cancer Research:
    The journal shows an increasing focus on the application of proteomics in cancer research, particularly in identifying biomarkers for diagnosis, prognosis, and treatment response, as well as understanding tumor biology.
  3. Immunoinformatics and Vaccine Development:
    Emerging studies are focusing on the use of proteomics in immunoinformatics for vaccine development. This includes the design of multi-epitope vaccines and the identification of immunogenic proteins from pathogens.
  4. Personalized Medicine and Precision Proteomics:
    There is a noticeable shift towards personalized medicine, with proteomics being leveraged to tailor treatments based on individual protein expression profiles and responses to therapies.
  5. Computational Advancements and Machine Learning:
    The application of machine learning and artificial intelligence in analyzing proteomic data is on the rise, offering new tools for data interpretation and predictive modeling within proteomics.

Declining or Waning

While 'Current Proteomics' continues to evolve, certain themes and methodologies appear to be declining in prominence. This may reflect shifts in research focus or the maturation of certain areas within the field.
  1. Traditional Proteomic Approaches:
    There seems to be a waning interest in traditional proteomic methodologies, such as two-dimensional gel electrophoresis, as researchers increasingly favor more advanced techniques like mass spectrometry-based approaches that offer higher resolution and sensitivity.
  2. Basic Studies without Clinical Relevance:
    Research focusing solely on basic proteomic studies without clear clinical applications or implications is becoming less common. The journal appears to prioritize studies that connect proteomic data to disease mechanisms or therapeutic implications.
  3. Limited Scope of Plant Proteomics:
    Although plant proteomics has been a significant area of research, recent publications suggest a decline in studies focused exclusively on plant proteins, possibly due to a broader focus on human health and disease-related proteomics.

Similar Journals

Comparative Biochemistry and Physiology D-Genomics & Proteomics

Advancing Understanding Through Comparative Insights in Molecular Biology
Publisher: ELSEVIER SCIENCE INCISSN: 1744-117XFrequency: 4 issues/year

Comparative Biochemistry and Physiology D-Genomics & Proteomics, published by Elsevier Science Inc, is a premier journal in the realm of molecular biology and comparative physiology, with a focus on genomic and proteomic sciences. Recognized for its high-impact contributions, it holds a Q1 ranking in Animal Science and Zoology and was established with the vision of bridging gaps in our understanding of biological systems through experimental and comparative approaches. With an impressive Scopus ranking, this journal not only ranks among the top 12% in Animal Science and Zoology but also demonstrates commendable standings across various categories including Aquatic Science and Molecular Biology. The journal’s commitment to disseminating high-quality research makes it an essential resource for researchers, professionals, and students alike, allowing them to access critical studies that influence advancements in genomics and proteomics. While it operates under a traditional subscription model, its impactful findings are crucial for those aiming to enrich their knowledge and research capabilities in these pivotal scientific fields. Join us in exploring the transformative insights and developments that this esteemed journal has to offer for the study of genomics and proteomics.

JOURNAL OF PROTEOME RESEARCH

Unveiling the Secrets of Protein Interactions
Publisher: AMER CHEMICAL SOCISSN: 1535-3893Frequency: 6 issues/year

JOURNAL OF PROTEOME RESEARCH is a premier publication in the field of proteomics, disseminating cutting-edge research and methodologies that drive advancements in biochemistry and molecular biology. Published by the American Chemical Society, this esteemed journal boasts a robust impact, as evidenced by its Q1 rankings in both Biochemistry and miscellaneous Chemistry categories for 2023. With a reputation bolstered by a solid Scopus ranking—#64 out of 408 in General Chemistry and #80 out of 438 in Biochemistry—the journal serves as an essential resource for researchers, professionals, and students aiming to deepen their understanding of protein functions and interactions in biological systems. Although it does not operate under an open-access model, the JOURNAL OF PROTEOME RESEARCH remains a critical platform for scholarly discourse, committed to publishing high-quality, peer-reviewed articles through 2024 and beyond. Scholars are encouraged to engage with the pioneering studies and reviews that shape the future of proteomics.

Expert Review of Proteomics

Pioneering Reviews in the World of Proteomics.
Publisher: TAYLOR & FRANCIS LTDISSN: 1478-9450Frequency: 6 issues/year

Expert Review of Proteomics, published by TAYLOR & FRANCIS LTD, is a distinguished journal that focuses on the latest advancements in the field of proteomics, a critical area within biochemistry and molecular biology. With an ISSN of 1478-9450 and E-ISSN 1744-8387, this journal has been pivotal in disseminating high-quality research from its inception in 2004 to its planned convergence in 2024. Its influential position is reflected in its 2023 rankings, placing it in the Q2 category for both Biochemistry and Molecular Biology, alongside respectable Scopus rankings that rank it 118th and 141st in its respective categories. Despite its non-open access structure, Expert Review of Proteomics provides researchers and professionals with a vital platform for critical reviews and insights into proteomic methodologies, thus contributing significantly to the global scientific community. By bridging theoretical research with practical applications, it serves as an essential resource for those dedicated to advancing their knowledge and expertise in this dynamic field.

PROTEIN AND PEPTIDE LETTERS

Bridging theory and application in the world of proteins and peptides.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 0929-8665Frequency: 12 issues/year

PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.

Journal of Biochemistry

Unveiling the mysteries of life at the molecular level.
Publisher: OXFORD UNIV PRESSISSN: 0021-924XFrequency: 12 issues/year

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.

ACS Chemical Biology

Driving Innovation in Biochemistry and Molecular Medicine
Publisher: AMER CHEMICAL SOCISSN: 1554-8929Frequency: 12 issues/year

ACS Chemical Biology is a premier journal published by the American Chemical Society, dedicated to advancing the understanding of the chemical underpinnings of biological systems. With an ISSN of 1554-8929 and a distinguished track record since its inception in 2006, this journal provides a vital platform for the dissemination of high-quality research in the realms of biochemistry and molecular medicine, achieving a prestigious Q1 ranking in these categories as of 2023. In an era where interdisciplinary approaches are crucial, ACS Chemical Biology fosters collaboration among chemists and biologists, reflecting a steadfast commitment to exploring the chemical processes that govern life. Although it does not operate under an open-access model, the journal maintains a rigorous peer-review process, ensuring the publication of influential studies that shape the future of chemical biology. With an increasing impact factor and a focus on innovative research, ACS Chemical Biology remains an authoritative resource for researchers, professionals, and students eager to engage with cutting-edge findings in this dynamic field.

JOURNAL OF BIOLOGICAL CHEMISTRY

Illuminating Breakthroughs in Molecular Biology
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

JOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.

Biochemistry Research International

Catalyzing global communication in the realm of biochemistry.
Publisher: HINDAWI LTDISSN: 2090-2247Frequency: 1 issue/year

Biochemistry Research International is a prominent and dynamic journal published by Hindawi Ltd, dedicated to advancing knowledge in the field of biochemistry. With its Open Access model established since 2010, the journal provides unrestricted access to high-quality research, thereby fostering global communication among researchers and professionals. Operating out of the United States, Biochemistry Research International serves as a vital platform for disseminating cutting-edge findings in biochemistry and molecular biology, holding a respectable Q2 ranking in its category as of 2023. The journal's scope encompasses a wide array of topics including but not limited to biochemical processes, genetic engineering, and molecular interactions, making it an essential resource for students and seasoned researchers alike. With an impact factor reflective of its significance in the academic community, Biochemistry Research International continues to play an integral role in shaping the future of biochemistry research.

PROTEOMICS

Shaping the future of life sciences through proteomic research.
Publisher: WILEYISSN: 1615-9853Frequency: 24 issues/year

PROTEOMICS is a leading journal focused on the rapidly evolving field of proteomics, published by WILEY in Germany. With a solid reputation established since its inception in 2001, it has continually contributed to the understanding of protein functions and interactions within biological systems. As part of its commitment to academic excellence, PROTEOMICS is ranked in the second quartile for both Biochemistry and Molecular Biology categories (2023), reflecting its significant influence in advancing research in these areas. Although it does not currently provide open access options, it remains a vital resource for researchers, professionals, and students keen to explore innovative methodologies and findings in proteomic research. By publishing groundbreaking studies that bridge theoretical knowledge with practical applications, PROTEOMICS plays a crucial role in enhancing our understanding of molecular processes and driving forward advancements in the life sciences.

COMPUTATIONAL BIOLOGY AND CHEMISTRY

Illuminating the Path of Innovation in Biochemistry through Computational Insights
Publisher: ELSEVIER SCI LTDISSN: 1476-9271Frequency: 6 issues/year

COMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.